Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and PerspectivesReview Published on 2020-06-302022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] acute respiratory syndrome Antiviral antiviral drug association China clinician coronavirus COVID-19 current described drug Efficacy Evidence guideline identify International Laboratory life-threatening Lopinavir Lopinavir/ritonavir MERS Middle East ongoing trial organ damage pandemic randomized clinical trial randomized trial recommendation recommendations Respiratory illness review Ritonavir role SARS searched syndrome Treatment viral replication viral-induced website Wuhan [DOI] 10.3390/jcm9072050 PMC 바로가기 [Article Type] Review
The efficacy and safety of Jinhua Qinggan granule (JHQG) in the treatment of coronavirus disease 2019 (COVID-19) A protocol for systematic review and meta analysis3800 Published on 2020-06-122022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] adverse events Analysis Anxiety appears CBM China Chinese clinical clinical trial CNKI coronavirus disease COVID-19 COVID-19, protocol database death Efficacy and safety evaluate Evidence exceeded Fang Google Government Infrastructure Jinhua Qinggan Granule journal Meta-analysis Novel coronavirus number of infected ongoing trial patients with COVID-19 peer-reviewed platform Primary outcome promoted protocol registry secondary outcome submitted Symptom syndrome systematic review TCM Treatment VIP was used Web of Science [DOI] 10.1097/MD.0000000000020531 PMC 바로가기 [Article Type] 3800
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipelineAnti-SARS-CoV-2 중화 단일클론항체: 임상 파이프라인Article Published on 2020-01-012022-09-11 Journal: mAbs [Category] MERS, SARS, 유전자 메커니즘, 임상, 진단, [키워드] anti-SARS-CoV-2 antibody bamlanivimab BGB-DXP593 candidate clinical trials Convalescent plasma therapy COVID-19 COVID-19 pandemic CT-P59 disease Ebolavirus Efficacy focus GSK4182136 LY-CoV016 LY-CoV555 mAb mAb cocktails mAbs mechanism mechanism of action monoclonal monoclonal antibody Neutralizing ongoing trial ongoing trials phase Phase 2 Pneumonia REGN-CoV2 Research research and development respiratory syncytial virus SARS-CoV-2 therapy VIR-7831 Viral viral infections virus pneumonia while [DOI] 10.1080/19420862.2020.1854149 PMC 바로가기 [Article Type] Article